Amundi
PRCT icon

Amundi’s Procept Biorobotics PRCT Stock Holding History

Amundi’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Buy
100,539
+77,145
+330% +$1.93M ﹤0.01% 1151
2026
Q1 		$585K Buy
23,394
+3,260
+16% +$91.9K ﹤0.01% 1488
2025
Q4 		$633K Buy
20,134
+837
+4% +$27.8K ﹤0.01% 1390
2025
Q3 		$680K Hold
19,297
– – ﹤0.01% 1251
2025
Q2 		$1.12M Sell
19,297
-852
-4% -$48.2K ﹤0.01% 1180
2025
Q1 		$1.1M Buy
20,149
+6
+0% +$410 ﹤0.01% 1305
2024
Q4 		$1.74M Buy
20,143
+183
+0.9% +$15.6K ﹤0.01% 1238
2024
Q3 		$1.48M Sell
19,960
-1,742
-8% -$124K ﹤0.01% 1210
2024
Q2 		$1.38M Hold
21,702
– – ﹤0.01% 1168
2024
Q1 		$1.11M Hold
21,702
– – ﹤0.01% 1262
2023
Q4 		$1.05M Sell
21,702
-5,058
-19% -$172K ﹤0.01% 1320
2023
Q3 		$721K Buy
26,760
+10,130
+61% +$345K ﹤0.01% 1359
2023
Q2 		$590K Buy
16,630
+15,494
+1,364% +$512K ﹤0.01% 1357
2023
Q1 		$36.5K Hold
1,136
– – ﹤0.01% 1918
2022
Q4 		$36.9K Buy
+1,136
New +$48.8K ﹤0.01% 1740

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Amundi's PRCT Position: Q2 2026 in Review

Amundi increased its Procept Biorobotics (PRCT) stake by 330% in Q2 2026, buying an estimated $1.93M and bringing the position to 100,539 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1151.

Amundi first reported a position in PRCT in Q4 2022 and has held it in 15 quarters since. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Amundi held 100,539 shares of Procept Biorobotics worth $2.27M as of Q2 2026.
  • Amundi bought 77,145 Procept Biorobotics shares in Q2 2026, an estimated $1.93M.
  • Procept Biorobotics made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1151 holding.
  • Amundi first reported a position in Procept Biorobotics in Q4 2022 and has held it in 15 quarters since.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.